American Portfolios Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
SOS
RJFSA
BFG
American Portfolios Advisors's FBT Position: Q3 2022 in Review
American Portfolios Advisors reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 4.3% in Q3 2022, selling an estimated $34.4K and leaving 5,400 shares worth $713K. The position accounts for 0.03% of the portfolio, ranked #527.
American Portfolios Advisors first reported a position in FBT in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.18M in Q1 2021. 218 funds tracked by Wall St. Rank hold FBT as of Q3 2022.
- American Portfolios Advisors held 5,400 shares of First Trust NYSE Arca Biotechnology Index Fund worth $713K as of Q3 2022.
- American Portfolios Advisors sold 245 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2022, an estimated $34.4K.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of American Portfolios Advisors's portfolio in Q3 2022, its #527 holding.
- American Portfolios Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2017 and has held it in 20 quarters since.
- American Portfolios Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.18M in Q1 2021.
- 218 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.